Topical testosterone for lichen sclerosus
- 1 November 1989
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 30 (3) , 253-255
- https://doi.org/10.1016/0020-7292(89)90412-8
Abstract
Twenty-three patients diagnosed as lichen sclerosus with colposcopic directed biopsy were given topical testosterone as a first line therapy. The overall remission rate was found to be 87.7%; 8.7% of the patients experienced undesirable androgenic side effects. Of the three patients who did not respond satisfactorily to testosterone treatment, two had alcohol injection to the vulva and one had vulvar denervation.Keywords
This publication has 14 references indexed in Scilit:
- Vulvar DystrophiesClinical Obstetrics and Gynecology, 1986
- Vulvar DystrophyClinical Obstetrics and Gynecology, 1985
- Genetic aspects of vulvar lichen sclerosusAmerican Journal of Obstetrics and Gynecology, 1984
- Serum Levels of Sex Hormones in Vulvar Lichen Sclerosus, and the Effect of Topical TestosteroneNew England Journal of Medicine, 1984
- Direct evidence of localised immunological damage in vulvar lichen sclerosus et atrophicus.Journal of Clinical Pathology, 1982
- An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus and atrophicusBritish Journal of Dermatology, 1981
- VULVAR DYSTROPHIESClinical Obstetrics and Gynecology, 1978
- The conversion of testosterone to 5α-Androstan-17β-ol-3-one (dihydrotestosterone) by Skin Slices Of manJournal of Clinical Investigation, 1969
- Postmenopausal Pruritus VulvaeAmerican Journal of Obstetrics and Gynecology, 1945
- EFFECT OF ANDROGEN ON THE SEBACEOUS GLANDS OF HUMAN SKINArchives of Dermatology, 1943